Secrets Of The Forest: S1 Episode 1 Magic Moss
Explore Your World
Environment & Sustainability
Conversation Starter
Watch
Article share options Share this on Facebook
Twitter Send this by Email
Copy link
Messenger
Join host Taviss and top scientists and conservationists, as they adventure across Canada to get to the bottom of the forest's many mysteries. Secrets of the Forest puts our Earth's precious forests in the spotlight.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Australian
a day ago
- The Australian
FDA clinical hold lift closer for Neurizon
Special Report: Neurizon Therapeutics has submitted a formal response to the US Food and Drug Administration (FDA) addressing the clinical hold on its Investigational New Drug (IND) application for its lead drug NUZ-001. Neurizon submits formal response to US FDA to resolve NUZ-001 clinical hold Submission includes new bridging PK data to demonstrate comprehensive exposure data in rats and dogs FDA review underway with Neurizon targeting participation in HEALEY trial in Q4 CY25 Neurizon Therapeutics (ASX:NUZ) a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, said the clinical hold complete response (CHCR) includes new bridging pharmacokinetic (PK) data from 28-day studies in rats and dogs. The PK studies were completed ahead of schedule and designed to address the FDA's request for more comprehensive animal exposure data to support safety margins of NUZ-001, the company's lead therapy for amyotrophic lateral sclerosis (ALS), and its primary sulfone metabolite. The response was submitted following constructive FDA engagement with the new PK results demonstrating: Greater than 10-fold safety margins based on projected human plasma exposure levels for both NUZ-001 and its active sulfone metabolite Enhanced confidence in dose selection and systemic tolerability to support progression to Phase 2/3 clinical evaluation FDA review of the CHCR is now underway and Neurizon expects formal feedback within 30 calendar days, in line with the regulator's standard statutory review period for hold responses. Focus on advancing into HEALEY ALS Platform trial The formal response to the FDA marks a significant step toward lifting the clinical hold on NUZ-001 and initiating enrolment in the HEALEY ALS Platform Trial, anticipated in Q4 CY25. ALS is the most common form of motor neurone disease (MND) and the HEALEY ALS Platform Trial is a significant ongoing program in the US aimed at accelerating ALS treatment development. 'With continued momentum and scientific clarity, we are advancing NUZ-001 toward a potentially first-in-class therapy for ALS, aligned with our commitment to create meaningful treatment options for patients,' managing director and CEO Dr Michael Thurn said. 'This submission underscores our disciplined execution and ability to deliver critical development milestones ahead of schedule. 'By proactively completing the required PK studies, we have significantly de-risked the regulatory path moving forward. 'We anticipate resolution of the clinical hold in August 2025, positioning Neurizon to initiate participation in the HEALEY ALS Platform Trial before year-end." This article was developed in collaboration with Neurizon Therapeutics, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
ABC News
4 days ago
- ABC News
Search on for how and where SA's algal bloom started, and where it's going
As South Australia's algal bloom creeps along the state's coasts, scientists are trying to find out what caused it, where it started and where it is heading next. The current bloom was first reported on beaches on the southern tip of the Fleurieu Peninsula in March before spreading across the Gulf of St Vincent. The federal and state governments have committed a combined $28 million to tackle the issue, some of which will be spent on research. University of Technology Sydney harmful algae bloom expert Professor Shauna Murray said the impact of the bloom was unprecedented in Australia. Professor Murray said while it was important to understand the chain of events that led to the bloom, more important was understanding how it could be quickly detected "so we can be prepared to respond to it", she said. "If it occurs then we know what to expect, we know what areas it might affect, we might understand a bit better how it will affect those areas." Though the first reports linked to the bloom were on Waitpinga Beach, estuarine ecologist Faith Coleman thinks fish kills further south and east could have been connected. "Areas like Portland in Victoria, and looking at the Eight Mile Creek [south of Mount Gambier], those places have had over the last couple of years [seen] a series of smaller blooms, best we can tell," Ms Coleman said. "Although they weren't investigated at the time, each one of those periods of large fish kills have tied into an extreme event relating to a large amount of seagrass death and seaweed death, and either exceptionally cold or hot waters. "We suspect that this particular bloom started somewhere near Robe." While it was not yet clear exactly where the bloom started, Flinders University Associate Professor Jochen Kaempf is trying to predict where it is going. He has developed a computer model to predict how the bloom could be developing. "It very likely becomes weaker and might disappear, or looks like disappearing," Dr Kaempf said. "The big question is whether it will turn up again when it gets warmer in the next summer months. "Will it maybe appear in the Spencer Gulf? [That] is way more concerning in terms of its ecological significance. "We have the sardine stock, the prawns, the cuttlefish. That's a big concern." The state government has said a marine heatwave, nutrients washing into the sea from the 2022-'23 River Murray flood, and an "unprecedented" cold-water upwelling in the summer of 2023-'24 are plausible contributing factors to the bloom. Dr Kaempf discovered the Great Southern Australian Coastal Upwelling System and has been studying it for more than two decades. The event attracts a range of marine life, including dolphins and whales. Dr Kaempf said there would not be a relationship between the 2023-'24 upwelling and the current bloom as blooms develop over the course of one to two months. "It's just too long ago and not linked to the bloom that we're seeing now," he said. Ms Coleman said the impacts of the upwelling on the algal bloom are likely to be insignificant compared to the marine heatwave. "What happened is what always happens — which is that it blows a little bit of extra nutrients that it's accumulated over time up into the main water column," she said. "Those were immediately taken up by a diatom bloom that you could see from space." Ms Coleman said the government likely has not had time to rule out the upwelling or flood as contributing factors. "Even SARDI and PIRSA reports say quite clearly the primary cause is climate change," she said. South Australia's Department for Primary Industries and Regions was contacted for comment.
ABC News
7 days ago
- ABC News
Scientist holding a donated brain
Australian scientists have found the first evidence of an unusual pattern of brain scarring only seen in people repeatedly exposed to blast waves.
